Tiludronic acid: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Tiludronic Acid == | |||
[[File:Tiludronic_acid.svg|thumb|right|Chemical structure of Tiludronic Acid]] | |||
'''Tiludronic acid''' is a [[bisphosphonate]] drug used primarily in the treatment of [[Paget's disease of bone]] and other conditions involving abnormal bone metabolism. It is known for its ability to inhibit bone resorption, which is the process by which bone is broken down and its minerals released into the bloodstream. | |||
Tiludronic acid | |||
== | == Mechanism of Action == | ||
Tiludronic acid | Tiludronic acid works by binding to [[hydroxyapatite]] crystals in the bone matrix, thereby inhibiting the activity of [[osteoclasts]], the cells responsible for bone resorption. This action helps to maintain bone density and reduce the risk of fractures in patients with bone disorders. | ||
== | == Clinical Uses == | ||
Tiludronic acid is primarily indicated for the treatment of [[Paget's disease]], a chronic disorder that can result in enlarged and misshapen bones. It may also be used off-label for other conditions that involve excessive bone turnover, such as [[osteoporosis]] and certain types of [[bone metastases]]. | |||
== | == Administration and Dosage == | ||
Tiludronic acid is typically administered orally. The dosage and duration of treatment depend on the specific condition being treated and the patient's overall health status. It is important for patients to follow their healthcare provider's instructions carefully to achieve optimal results. | |||
* [[Paget's disease]] | == Side Effects == | ||
* [[ | Common side effects of tiludronic acid include gastrointestinal disturbances such as [[nausea]], [[vomiting]], and [[diarrhea]]. More serious side effects can include [[esophageal irritation]] and [[osteonecrosis of the jaw]], although these are rare. | ||
== Pharmacokinetics == | |||
Tiludronic acid is absorbed in the gastrointestinal tract and is primarily excreted unchanged in the urine. Its bioavailability can be affected by food intake, so it is often recommended to take the medication on an empty stomach. | |||
== Related Pages == | |||
* [[Bisphosphonate]] | |||
* [[Paget's disease of bone]] | |||
* [[Osteoclast]] | |||
* [[Bone resorption]] | |||
[[Category:Bisphosphonates]] | [[Category:Bisphosphonates]] | ||
[[Category: | [[Category:Bone disorders]] | ||
Latest revision as of 12:08, 15 February 2025
Tiludronic Acid[edit]
Tiludronic acid is a bisphosphonate drug used primarily in the treatment of Paget's disease of bone and other conditions involving abnormal bone metabolism. It is known for its ability to inhibit bone resorption, which is the process by which bone is broken down and its minerals released into the bloodstream.
Mechanism of Action[edit]
Tiludronic acid works by binding to hydroxyapatite crystals in the bone matrix, thereby inhibiting the activity of osteoclasts, the cells responsible for bone resorption. This action helps to maintain bone density and reduce the risk of fractures in patients with bone disorders.
Clinical Uses[edit]
Tiludronic acid is primarily indicated for the treatment of Paget's disease, a chronic disorder that can result in enlarged and misshapen bones. It may also be used off-label for other conditions that involve excessive bone turnover, such as osteoporosis and certain types of bone metastases.
Administration and Dosage[edit]
Tiludronic acid is typically administered orally. The dosage and duration of treatment depend on the specific condition being treated and the patient's overall health status. It is important for patients to follow their healthcare provider's instructions carefully to achieve optimal results.
Side Effects[edit]
Common side effects of tiludronic acid include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. More serious side effects can include esophageal irritation and osteonecrosis of the jaw, although these are rare.
Pharmacokinetics[edit]
Tiludronic acid is absorbed in the gastrointestinal tract and is primarily excreted unchanged in the urine. Its bioavailability can be affected by food intake, so it is often recommended to take the medication on an empty stomach.
